REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
